Concentration: 1.0 mg/mL in 1 mM Sodium Citrate, pH 6.4
mRNA length: 1474 nucleotides.
MW MRNA52= 475220 g/mol; MRNA53= 483860 g/mol; MRNA54= 479540 g/mol.
 
N SARS-Cov-2 mRNA has been designed to produce high expression level of the nucleocapsid protein of SARS-CoV-2 virus.
OZB mRNAs are produced by in vitro transcription. mRNAs are stabilized at the 5’ end by modified nucleotides capping (Cap1) and contain a poly(A) tail at the 3’ end. Sequences have been optimized to yield improved stability and performance.
N SARS-Cov-2 mRNAs:
	- 
	#MRNA52 does not bear any additional nucleotide modifications. 
- 
	#MRNA53 is modified with 5-methoxyuridine (5moU) to reduce innate immune response. 
- 
	#MRNA54 is modified with N1-methyl-pseudouridine (N1-mψ) to reduce innate immune response. 
 
Size: 20 µg, 100µg or 1 mg.
Storage: -80°C
mRNAs ARE SHIPPED WITH DRY ICE
 
	
		
			| CATALOG NUMBER | UNIT SIZE | 
	
	
		
			| MRNA52-20 | Unmodified N SARS-Cov-2 mRNA 20 µg | 
		
			| MRNA52-100 | Unmodified N SARS-Cov-2 mRNA 100 µg | 
		
			| MRNA52-1000 | Unmodified N SARS-Cov-2 mRNA 1 mg | 
		
			| MRNA53-20 | N SARS-Cov-2 mRNA (5moU) 20 µg | 
		
			| MRNA53-100 | N SARS-Cov-2 mRNA (5moU) 100 µg | 
		
			| MRNA53-1000 | N SARS-Cov-2 mRNA (5moU) 1 mg | 
		
			| MRNA54-20 | N SARS-Cov-2 mRNA (N1-mψ) 20 µg | 
		
			| MRNA54-100 | N SARS-Cov-2 mRNA (N1-mψ) 100 µg | 
		
			| MRNA54-1000 | N SARS-Cov-2 mRNA (N1-mψ) 1 mg |